351 related articles for article (PubMed ID: 11585338)
21. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
[TBL] [Abstract][Full Text] [Related]
22. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.
Yu VW; Ambartsoumian G; Verlinden L; Moir JM; Prud'homme J; Gauthier C; Roughley PJ; St-Arnaud R
J Cell Biol; 2005 May; 169(4):591-601. PubMed ID: 15911876
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo.
Edwards JR; Nyman JS; Lwin ST; Moore MM; Esparza J; O'Quinn EC; Hart AJ; Biswas S; Patil CA; Lonning S; Mahadevan-Jansen A; Mundy GR
J Bone Miner Res; 2010 Nov; 25(11):2419-26. PubMed ID: 20499365
[TBL] [Abstract][Full Text] [Related]
24. Osteoblast-specific expression of MEF induces osteopenia through downregulation of osteoblastogenesis and upregulation of osteoclastogenesis.
Seul KJ; Cho HS; Heo SH; Baek WY; Kim JE; Park EK; Choi JY; Ryoo HM; Cho JY
J Bone Miner Res; 2011 Feb; 26(2):341-50. PubMed ID: 20715187
[TBL] [Abstract][Full Text] [Related]
25. Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling.
McGregor NE; Poulton IJ; Walker EC; Pompolo S; Quinn JM; Martin TJ; Sims NA
Calcif Tissue Int; 2010 Mar; 86(3):261-70. PubMed ID: 20157807
[TBL] [Abstract][Full Text] [Related]
26. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects.
Kenner L; Hoebertz A; Beil FT; Keon N; Karreth F; Eferl R; Scheuch H; Szremska A; Amling M; Schorpp-Kistner M; Angel P; Wagner EF
J Cell Biol; 2004 Feb; 164(4):613-23. PubMed ID: 14769860
[TBL] [Abstract][Full Text] [Related]
27. Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species.
Zhou H; Newnum AB; Martin JR; Li P; Nelson MT; Moh A; Fu XY; Yokota H; Li J
Bone; 2011 Sep; 49(3):404-11. PubMed ID: 21555004
[TBL] [Abstract][Full Text] [Related]
28. Zinc finger protein 521, a new player in bone formation.
Hesse E; Kiviranta R; Wu M; Saito H; Yamana K; Correa D; Atfi A; Baron R
Ann N Y Acad Sci; 2010 Mar; 1192():32-7. PubMed ID: 20392215
[TBL] [Abstract][Full Text] [Related]
29. Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability.
Moon YJ; Yun CY; Choi H; Ka SO; Kim JR; Park BH; Cho ES
Exp Mol Med; 2016 Sep; 48(9):e256. PubMed ID: 27585718
[TBL] [Abstract][Full Text] [Related]
30. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.
Ogata N; Chikazu D; Kubota N; Terauchi Y; Tobe K; Azuma Y; Ohta T; Kadowaki T; Nakamura K; Kawaguchi H
J Clin Invest; 2000 Apr; 105(7):935-43. PubMed ID: 10749573
[TBL] [Abstract][Full Text] [Related]
31. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards.
Jilka RL; Weinstein RS; Parfitt AM; Manolagas SC
J Bone Miner Res; 2007 Oct; 22(10):1492-501. PubMed ID: 17542686
[TBL] [Abstract][Full Text] [Related]
32. Osteogenic effects of a potent Src-over-Abl-selective kinase inhibitor in the mouse.
Murrills RJ; Fukayama S; Boschelli F; Matteo JJ; Owens J; Golas JM; Patel D; Lane G; Liu YB; Carter L; Jussif J; Spaulding V; Wang YD; Boschelli DH; McKew JC; Li XJ; Lockhead S; Milligan C; Kharode YP; Diesl V; Bai Y; Follettie M; Bex FJ; Komm B; Bodine PV
J Pharmacol Exp Ther; 2012 Mar; 340(3):676-87. PubMed ID: 22171089
[TBL] [Abstract][Full Text] [Related]
33. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
[TBL] [Abstract][Full Text] [Related]
34. Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model.
Rantakokko J; Uusitalo H; Jämsä T; Tuukkanen J; Aro HT; Vuorio E
J Bone Miner Res; 1999 Nov; 14(11):1934-42. PubMed ID: 10571694
[TBL] [Abstract][Full Text] [Related]
35. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
36. TGF-beta regulates the mechanical properties and composition of bone matrix.
Balooch G; Balooch M; Nalla RK; Schilling S; Filvaroff EH; Marshall GW; Marshall SJ; Ritchie RO; Derynck R; Alliston T
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18813-8. PubMed ID: 16354837
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of bone anabolic action by PTH].
Kaji H
Clin Calcium; 2012 Mar; 22(3):321-6. PubMed ID: 22370298
[TBL] [Abstract][Full Text] [Related]
38. 1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue.
Aschenbrenner JK; Sollinger HW; Becker BN; Hullett DA
J Surg Res; 2001 Oct; 100(2):171-5. PubMed ID: 11592788
[TBL] [Abstract][Full Text] [Related]
39. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation.
Johnson RW; Brennan HJ; Vrahnas C; Poulton IJ; McGregor NE; Standal T; Walker EC; Koh TT; Nguyen H; Walsh NC; Forwood MR; Martin TJ; Sims NA
J Bone Miner Res; 2014 Jun; 29(6):1492-505. PubMed ID: 24339143
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage.
Yang X; Chen L; Xu X; Li C; Huang C; Deng CX
J Cell Biol; 2001 Apr; 153(1):35-46. PubMed ID: 11285272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
